Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Eflapegrastim

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Assertio Shares Rolvedon® Same-Day Dosing Study Results
    Assertio Shares Rolvedon® Same-Day Dosing Study Results

    13 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/13/2996766/0/en/Assertio-Announces-Results-of-Rolvedon-eflapegrastim-xnst-injection-Same-Day-Dosing-Clinical-Study.html

    GLOBENEWSWIRE
    13 Dec 2024
    Share Share
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.

    16 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761148

    FDA
    16 Jun 2023
    Share Share
    Spectrum Receives Permanent J-Code for ROLVEDON Injection from U.S. CMS
    Spectrum Receives Permanent J-Code for ROLVEDON Injection from U.S. CMS

    08 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230208005310/en

    BUSINESSWIRE
    08 Feb 2023
    Share Share
    Spectrum Pharmaceuticals Provides Update on ROLVEDON Injection
    Spectrum Pharmaceuticals Provides Update on ROLVEDON Injection

    31 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230131005344/en

    BUSINESSWIRE
    31 Jan 2023
    Share Share
    Spectrum Pharma’s ROLVEDON Injection Added to NCCN Supportive Care Guidelines
    Spectrum Pharma’s ROLVEDON Injection Added to NCCN Supportive Care Guidelines

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005351/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share
    Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON Injection
    Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON Injection

    09 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220909005522/en

    BUSINESSWIRE
    09 Sep 2022
    Share Share